首页> 外文OA文献 >Estimating Survival in Patients with Non-Small-Cell Lung Cancer and Brain Metastases: A Verification of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA)

【2h】

Estimating Survival in Patients with Non-Small-Cell Lung Cancer and Brain Metastases: A Verification of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA)

机译：估算非小细胞肺癌和脑转移患者的存活：使用分子标记进行肺癌评分预后评估的验证（肺钼糖）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Ji Li; Wang Jing; Xiaoyang Zhai; Wenxiao Jia; Hui Zhu; Jinming Yu;
展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Validation of the graded prognostic assessment for lung cancer with brain metastases using molecular markers (lung-molGPA) [J] . Carsten Nieder, Mandy Hintz, Oliver Oehlke, Radiation oncology . 2017,第1期

机译：使用分子标志物（lung-molGPA）验证患有脑转移的肺癌的分级预后评估
2. Lung-molGPA Index Predicts Survival Outcomes of Non-Small-Cell Lung Cancer Patients with Synchronous or Metachronous Brain Metastases [J] . Kaiyan Chen, Fanrong Zhang, Yun Fan, OncoTargets and therapy . 2020,第2期

机译：肺莫尔格帕指数预测非小细胞肺癌患者的生存结果同步或同落脑转移
3. Applicability of the adjusted graded prognostic assessment for lung cancer with brain metastases using molecular markers (Lung‐molGPA) in a Chinese cohort: A retrospective study of multiple institutions [J] . Tingyou Zhang, Yu Zhang, Lin Zhou, Cancer Medicine . 2020,第23期

机译：用分子标记（肺部MolgPA）在中国队列中对肺癌进行调整后预后评估的适用性：多种机构的回顾性研究
4. Identification of Rules for Brain Metastases and Survival Time Prediction for Small Cell Lung Cancer Patients [C] . Kwei Aryeetey, Wojciech Ziarko, Patricia Tai, International Symposium on "Intelligent Information Systems X", Jun 18-22, 2001, Zakopane, Poland . 2001

机译：小细胞肺癌患者脑转移和生存时间预测规则的确定
5. Subgroup analysis based on prognostic and predictive gene signatures for adjuvant chemotherapy in early-stage non-small-cell lung cancer patients [D] . Pluta, Dustin. 2015

机译：基于预后和预测基因特征的亚组分析用于早期非小细胞肺癌患者的辅助化疗
6. Estimating Survival in Patients with Non-Small-Cell Lung Cancer and Brain Metastases: A Verification of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA) [O] . Ji Li, Wang Jing, Xiaoyang Zhai, 2021

机译：估算非小细胞肺癌和脑转移患者的存活：使用分子标记进行肺癌评分预后评估的验证（肺钼糖）
7. Validation of the graded prognostic assessment for lung cancer with brain metastases using molecular markers (lung-molGPA) [O] . Carsten Nieder, Mandy Hintz, Oliver Oehlke, 2017

机译：利用分子标记验证肺癌肺癌评分预后评估（肺钼酸）

Estimating Survival in Patients with Non-Small-Cell Lung Cancer and Brain Metastases: A Verification of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA)

著录项

引文网络

相似文献

相关主题

期刊订阅